1. Yamaguchi T, Imada H, Iida S, et al. Notochordal tumors: an update on molecular pathology with therapeutic implications. Surg Pathol Clin 2017;10:637-56.
2. Yamaguchi T, Suzuki S, Ishiiwa H, et al. Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs. Am J Surg Pathol 2004;28:756-61.
4. Gokaslan ZL, Zadnik PL, Sciubba DM, et al. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database. J Neurosurg Spine 2016;24:644-51.
5. Hulen CA, Temple HT, Fox WP, et al. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am 2006;88:1532-9.
7. Bailey CS, Fisher CG, Boyd MC, et al.
En bloc marginal excision of a multilevel cervical chordoma. Case report. J Neurosurg Spine 2006;4:409-14.
8. McMaster ML, Goldstein AM, Bromley CM, et al. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 2001;12:1-11.
9. Denaro L, Berton A, Ciuffreda M, et al. Surgical management of chordoma: a systematic review. J Spinal Cord Med 2020;43:797-812.
10. Casali PG, Stacchiotti S, Sangalli C, et al. Chordoma. Curr Opin Oncol 2007;19:367-70.
11. Sciubba DM, Chi JH, Rhines LD, et al. Chordoma of the spinal column. Neurosurg Clin N Am 2008;19:5-15.
12. Mirra JM, Nelson SD, Della Rocca C, et al. Chordoma. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon (France): IARC Press; 2002. p.316-7. (World Health Organization classification of tumours).
13. Bjornsson J, Wold LE, Ebersold MJ, et al. Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients. Cancer 1993;71:735-40.
14. Ahmed R, Sheybani A, Menezes AH, et al. Disease outcomes for skull base and spinal chordomas: a single center experience. Clin Neurol Neurosurg 2015;130:67-73.
15. Sundaresan N, Huvos AG, Krol G, et al. Surgical treatment of spinal chordomas. Arch Surg 1987;122:1479-82.
17. Stener B, Gunterberg B. High amputation of the sacrum for extirpation of tumors. Spine (Phila Pa 1976) 1978;3:351-66.
18. Lee IJ, Lee RJ, Fahim DK. Prognostic factors and survival outcome in patients with chordoma in the United States: a population-based analysis. World Neurosurg 2017;104:346-55.
19. York JE, Kaczaraj A, Abi-Said D, et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 1999;44:74-80.
20. Lockney DT, Shub T, Hopkins B, et al. Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment. Neurosurg Focus 2017;42:E4.
21. Barrenechea IJ, Perin NI, Triana A, et al. Surgical management of chordomas of the cervical spine. J Neurosurg Spine 2007;6:398-406.
22. van Wulfften Palthe ODR, Tromp I, Ferreira A, et al. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution. Spine J 2019;19:869-79.
24. Boriani S, Bandiera S, Biagini R, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976) 2006;31:493-503.
25. Todd LT Jr, Yaszemski MJ, Currier BL, et al. Bowel and bladder function after major sacral resection. Clin Orthop Relat Res 2002;397:36-9.
26. Jing L, Wang G. Giant recurrent sacral chordoma. World Neurosurg 2019;122:96-7.
27. Lim JBT, Soeharno H, Tan MH. Sacral chordoma: clinical experience of a series of 11 patients over 18 years. Eur J Orthop Surg Traumatol 2019;29:9-15.
28. Yonemoto T, Tatezaki S, Takenouchi T, et al. The surgical management of sacrococcygeal chordoma. Cancer 1999;85:878-83.
29. Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg Focus 2003;15:1-5.
30. Zileli M, Hoscoskun C, Brastianos P, et al. Surgical treatment of primary sacral tumors: complications associated with sacrectomy. Neurosurg Focus 2003;15:E9.
31. Samson IR, Springfield DS, Suit HD, et al. Operative treatment of sacrococcygeal chordoma: a review of twenty-one cases. J Bone Joint Surg Am 1993;75:1476-84.
32. MacCraty CS, Waugh JM, Mayo CW, et al. The surgical treatment of presacral tumors: a combined problem. Proc Staff Meet Mayo Clin 1952;27:73-84.
33. Ruggieri MR, Braverman AS, D'Andrea L, et al. Functional reinnervation of the canine bladder after spinal root transection and immediate end-on-end repair. J Neurotrauma 2006;23:1125-36.
34. Xu Q, Gu H, Liu X, et al. Giant sacrococcygeal chordoma: a case report. Medicine (Baltimore) 2018;97:e13748.
35. Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003;10:291-6.
36. Nakai S, Yoshizawa H, Kobayashi S, et al. Role of autologous blood transfusion in sacral tumor resection: patient selection and recovery after surgery and blood donation. J Orthop Sci 2000;5:321-7.
37. Fourney DR, Rhines LD, Hentschel SJ, et al.
En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 2005;3:111-22.
39. Lee YH, Chung MS, Gong HS, et al. Sural nerve autografts for high radial nerve injury with nine centimeter or greater defects. J Hand Surg Am 2008;33:83-6.
40. Buntic RF, Buncke HJ, Kind GM, et al. The harvest and clinical application of the superficial peroneal sensory nerve for grafting motor and sensory nerve defects. Plast Reconstr Surg 2002;109:145-51.
42. Yu X, Kou C, Bai W, et al. Comparison of wide margin and inadequate margin for recurrence in sacral chordoma: a meta-analysis. Spine (Phila Pa 1976) 2020;45:814-9.
43. Patel S, Nunna RS, Nie J, et al. Incidence, management, and outcomes of adult spinal chordoma patients in the United States. Global Spine J 2021 Feb 15:2192568221995155
https://doi.org/10.1177/2192568221995155. [Epub].
44. Stacchiotti S, Sommer J, Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol 2015;16:e71-83.